Pathogenesis of influenza and SARS-CoV-2 co-infection at the extremes of age: decipher the ominous tales of immune vulnerability
- PMID: 39883362
- PMCID: PMC12443670
- DOI: 10.1007/s44307-025-00057-9
Pathogenesis of influenza and SARS-CoV-2 co-infection at the extremes of age: decipher the ominous tales of immune vulnerability
Abstract
The co-circulation of influenza and SARS-CoV-2 has led to co-infection events, primarily affecting children and older adults, who are at higher risk for severe disease. Although co-infection prevalence is relatively low, it is associated with worse outcomes compared to mono-infections. Previous studies have shown that the outcomes of co-infection depend on multiple factors, including viral interference, virus-host interaction and host response. Children and the elderly exhibit distinct patterns of antiviral response, which involve airway epithelium, mucociliary clearance, innate and adaptive immune cells, and inflammatory mediators. This review explores the pathogeneses of SARS-CoV-2 and influenza co-infection, focusing on the antiviral responses in children and the elderly. By comparing immature immunity in children and immune senescence in older adults, we aim to provide insights for the clinical management of severe co-infection cases.
Keywords: Co-infection; Immature immunity; Immunosenescence; Influenza; SARS-CoV-2.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: Not applicable. Consent for publication: All authors approved the manuscript for the submission to this journal. Competing interests: The authors declare no competing interest.
Figures
References
-
- Adams K, Tastad KJ, Huang S, Ujamaa D, Kniss K, Cummings C, et al. Prevalence of SARS-CoV-2 and influenza coinfection and clinical characteristics among children and adolescents aged <18 years who were hospitalized or died with influenza - United States, 2021–22 influenza season. MMWR Morb Mortal Wkly Rep. 2022;71(50):1589–96. 10.15585/mmwr.mm7150a4. - DOI - PMC - PubMed
Publication types
Grants and funding
- 82361168672/National Natural Science Foundation of China
- 82174053/National Natural Science Foundation of China
- 82341099/National Natural Science Foundation of China
- FDCT0111/2023/AFJ/Science and Technology Development Fund of Macau SAR, China
- 005/2022/ALC/Science and Technology Development Fund of Macau SAR, China
LinkOut - more resources
Full Text Sources
Miscellaneous
